{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:56:55Z","timestamp":1791061015771,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T00:00:00Z","timestamp":1247616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2202-10-77","type":"journal-article","created":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T18:13:38Z","timestamp":1247681618000},"source":"Crossref","is-referenced-by-count":23,"title":["Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of Cisplatin-induced neuropathy"],"prefix":"10.1186","volume":"10","author":[{"given":"Min-Suk","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaza","family":"Katsarava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Obermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sch\u00e4fers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Liedert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dzagnidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kribben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Egensperger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Limmroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Christoph","family":"Diener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Thomale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,15]]},"reference":[{"issue":"4","key":"1081_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF00839140","volume":"239","author":"M LoMonaco","year":"1992","unstructured":"LoMonaco M, Milone M, Batocchi AP, Padua L, Restuccia D, Tonali P: Cisplatin neuropathy: clinical course and neurophysiological findings. J Neurol. 1992, 239 (4): 199-204. 10.1007\/BF00839140.","journal-title":"J Neurol"},{"issue":"10","key":"1081_CR2","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1200\/JCO.1989.7.10.1457","volume":"7","author":"SW Hansen","year":"1989","unstructured":"Hansen SW, Helweg-Larsen S, Trojaborg W: Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer. J Clin Oncol. 1989, 7 (10): 1457-1461.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1081_CR3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1212\/WNL.34.7.934","volume":"34","author":"RI Roelofs","year":"1984","unstructured":"Roelofs RI, Hrushesky W, Rogin J, Rosenberg L: Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology. 1984, 34 (7): 934-938.","journal-title":"Neurology"},{"issue":"7","key":"1081_CR4","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/1097-0142(19841001)54:7<1269::AID-CNCR2820540707>3.0.CO;2-9","volume":"54","author":"SW Thompson","year":"1984","unstructured":"Thompson SW, Davis LE, Kornfeld M, Hilgers RD, Standefer JC: Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer. 1984, 54 (7): 1269-1275. 10.1002\/1097-0142(19841001)54:7<1269::AID-CNCR2820540707>3.0.CO;2-9.","journal-title":"Cancer"},{"issue":"Pt 5","key":"1081_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/brain\/116.5.1017","volume":"116","author":"A Krarup-Hansen","year":"1993","unstructured":"Krarup-Hansen A, Fugleholm K, Helweg-Larsen S, Hauge EN, Schmalbruch H, Trojaborg W, Krarup C: Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function. Brain. 1993, 116 (Pt 5): 1017-1041. 10.1093\/brain\/116.5.1017.","journal-title":"Brain"},{"key":"1081_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000411639","volume":"29","author":"BW Ongerboer de Visser","year":"1985","unstructured":"Ongerboer de Visser BW, Tiessens G: Polyneuropathy induced by cisplatin. Prog Exp Tumor Res. 1985, 29: 190-196.","journal-title":"Prog Exp Tumor Res"},{"issue":"16","key":"1081_CR7","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1021\/bi00131a013","volume":"31","author":"KM Comess","year":"1992","unstructured":"Comess KM, Burstyn JN, Essigmann JM, Lippard SJ: Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts. Biochemistry. 1992, 31 (16): 3975-3990. 10.1021\/bi00131a013.","journal-title":"Biochemistry"},{"issue":"47","key":"1081_CR8","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","volume":"22","author":"ZH Siddik","year":"2003","unstructured":"Siddik ZH: Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003, 22 (47): 7265-7279. 10.1038\/sj.onc.1206933.","journal-title":"Oncogene"},{"issue":"Pt 1","key":"1081_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3280001","volume":"328","author":"JE Cleaver","year":"1997","unstructured":"Cleaver JE, States JC: The DNA damage-recognition problem in human and other eukaryotic cells: the XPA damage binding protein. Biochem J. 1997, 328 (Pt 1): 1-12.","journal-title":"Biochem J"},{"issue":"6737","key":"1081_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/21323","volume":"399","author":"RD Wood","year":"1999","unstructured":"Wood RD: DNA repair. Variants on a theme. Nature. 1999, 399 (6737): 639-640. 10.1038\/21323.","journal-title":"Nature"},{"issue":"35","key":"1081_CR11","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1523\/JNEUROSCI.0523-07.2007","volume":"27","author":"A Dzagnidze","year":"2007","unstructured":"Dzagnidze A, Katsarava Z, Makhalova J, Liedert B, Yoon MS, Kaube H, Limmroth V, Thomale J: Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy. J Neurosci. 2007, 27 (35): 9451-9457. 10.1523\/JNEUROSCI.0523-07.2007.","journal-title":"J Neurosci"},{"issue":"41","key":"1081_CR12","doi-asserted-by":"publisher","first-page":"14907","DOI":"10.1073\/pnas.0406491101","volume":"101","author":"M Brines","year":"2004","unstructured":"Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, et al.: Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA. 2004, 101 (41): 14907-14912. 10.1073\/pnas.0406491101.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1081_CR13","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1046\/j.1460-9568.2003.02875.x","volume":"18","author":"WM Campana","year":"2003","unstructured":"Campana WM, Myers RR: Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury. Eur J Neurosci. 2003, 18 (6): 1497-1506. 10.1046\/j.1460-9568.2003.02875.x.","journal-title":"Eur J Neurosci"},{"issue":"8","key":"1081_CR14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03402029","volume":"8","author":"H Ehrenreich","year":"2002","unstructured":"Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, et al.: Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002, 8 (8): 495-505.","journal-title":"Mol Med"},{"issue":"2\u20133","key":"1081_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neulet.2004.08.080","volume":"371","author":"SC Keswani","year":"2004","unstructured":"Keswani SC, Leitz GJ, Hoke A: Erythropoietin is neuroprotective in models of HIV sensory neuropathy. Neurosci Lett. 2004, 371 (2\u20133): 102-105. 10.1016\/j.neulet.2004.08.080.","journal-title":"Neurosci Lett"},{"issue":"5","key":"1081_CR16","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1167\/iovs.03-1039","volume":"45","author":"JH Weishaupt","year":"2004","unstructured":"Weishaupt JH, Rohde G, Polking E, Siren AL, Ehrenreich H, Bahr M: Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci. 2004, 45 (5): 1514-1522. 10.1167\/iovs.03-1039.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"19","key":"1081_CR17","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","volume":"97","author":"ML Brines","year":"2000","unstructured":"Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A: Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA. 2000, 97 (19): 10526-10531. 10.1073\/pnas.97.19.10526.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1081_CR18","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ki.1997.55","volume":"51","author":"HH Marti","year":"1997","unstructured":"Marti HH, Gassmann M, Wenger RH, Kvietikova I, Morganti-Kossmann MC, Kossmann T, Trentz O, Bauer C: Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int. 1997, 51 (2): 416-418. 10.1038\/ki.1997.55.","journal-title":"Kidney Int"},{"issue":"10","key":"1081_CR19","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1096\/fj.00-0857fje","volume":"15","author":"WM Campana","year":"2001","unstructured":"Campana WM, Myers RR: Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. Faseb J. 2001, 15 (10): 1804-1806.","journal-title":"Faseb J"},{"issue":"3\u20134","key":"1081_CR20","first-page":"228","volume":"79","author":"C Dame","year":"2001","unstructured":"Dame C, Juul SE, Christensen RD: The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol Neonate. 2001, 79 (3\u20134): 228-235.","journal-title":"Biol Neonate"},{"issue":"6","key":"1081_CR21","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.20285","volume":"56","author":"SC Keswani","year":"2004","unstructured":"Keswani SC, Buldanlioglu U, Fischer A, Reed N, Polley M, Liang H, Zhou C, Jack C, Leitz GJ, Hoke A: A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann Neurol. 2004, 56 (6): 815-826. 10.1002\/ana.20285.","journal-title":"Ann Neurol"},{"issue":"1","key":"1081_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0014-4886(03)00003-7","volume":"182","author":"N Authier","year":"2003","unstructured":"Authier N, Gillet JP, Fialip J, Eschalier A, Coudore F: An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections. Exp Neurol. 2003, 182 (1): 12-20. 10.1016\/S0014-4886(03)00003-7.","journal-title":"Exp Neurol"},{"issue":"12","key":"1081_CR23","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1172\/JCI1130","volume":"101","author":"JS Gill","year":"1998","unstructured":"Gill JS, Windebank AJ: Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J Clin Invest. 1998, 101 (12): 2842-2850. 10.1172\/JCI1130.","journal-title":"J Clin Invest"},{"issue":"6","key":"1081_CR24","first-page":"883","volume":"20","author":"C Meijer","year":"1999","unstructured":"Meijer C, de Vries EG, Marmiroli P, Tredici G, Frattola L, Cavaletti G: Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy. Neurotoxicology. 1999, 20 (6): 883-887.","journal-title":"Neurotoxicology"},{"issue":"6","key":"1081_CR25","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkl051","volume":"34","author":"B Liedert","year":"2006","unstructured":"Liedert B, Pluim D, Schellens J, Thomale J: Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei. Nucleic Acids Res. 2006, 34 (6): e47-10.1093\/nar\/gkl051.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"1081_CR26","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1158\/1078-0432.CCR-05-2177","volume":"12","author":"R Bianchi","year":"2006","unstructured":"Bianchi R, Brines M, Lauria G, Savino C, Gilardini A, Nicolini G, Rodriguez-Menendez V, Oggioni N, Canta A, Penza P, et al.: Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity. Clin Cancer Res. 2006, 12 (8): 2607-2612. 10.1158\/1078-0432.CCR-05-2177.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1081_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nbd.2004.09.013","volume":"18","author":"ES McDonald","year":"2005","unstructured":"McDonald ES, Randon KR, Knight A, Windebank AJ: Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiol Dis. 2005, 18 (2): 305-313. 10.1016\/j.nbd.2004.09.013.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1081_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0921-8777(99)00025-7","volume":"434","author":"DL Croteau","year":"1999","unstructured":"Croteau DL, Stierum RH, Bohr VA: Mitochondrial DNA repair pathways. Mutat Res. 1999, 434 (3): 137-148.","journal-title":"Mutat Res"},{"issue":"2","key":"1081_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1006\/nbdi.2001.0468","volume":"9","author":"ES McDonald","year":"2002","unstructured":"McDonald ES, Windebank AJ: Cisplatin-induced apoptosis of DRG neurons involves bax redistribution and cytochrome c release but not fas receptor signaling. Neurobiol Dis. 2002, 9 (2): 220-233. 10.1006\/nbdi.2001.0468.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"1081_CR30","first-page":"1259","volume":"9","author":"KM Livesey","year":"2008","unstructured":"Livesey KM, Tang D, Zeh HJ, Lotze MT: Not just nuclear proteins: 'novel' autophagy cancer treatment targets \u2013 p53 and HMGB1. Curr Opin Investig Drugs. 2008, 9 (12): 1259-1263.","journal-title":"Curr Opin Investig Drugs"},{"issue":"9","key":"1081_CR31","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1021\/bi026972w","volume":"42","author":"Y Jung","year":"2003","unstructured":"Jung Y, Lippard SJ: Nature of full-length HMGB1 binding to cisplatin-modified DNA. Biochemistry. 2003, 42 (9): 2664-2671. 10.1021\/bi026972w.","journal-title":"Biochemistry"},{"issue":"2","key":"1081_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.exer.2007.11.010","volume":"86","author":"B Zhu","year":"2008","unstructured":"Zhu B, Wang W, Gu Q, Xu X: Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats. Exp Eye Res. 2008, 86 (2): 375-382. 10.1016\/j.exer.2007.11.010.","journal-title":"Exp Eye Res"},{"issue":"1","key":"1081_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1182\/blood.V94.1.87.413k41_87_96","volume":"94","author":"T Gregory","year":"1999","unstructured":"Gregory T, Yu C, Ma A, Orkin SH, Blobel GA, Weiss MJ: GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood. 1999, 94 (1): 87-96.","journal-title":"Blood"},{"issue":"5383","key":"1081_CR34","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","volume":"281","author":"CY Wang","year":"1998","unstructured":"Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS: NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 1998, 281 (5383): 1680-1683. 10.1126\/science.281.5383.1680.","journal-title":"Science"},{"issue":"6847","key":"1081_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/35088074","volume":"412","author":"M Digicaylioglu","year":"2001","unstructured":"Digicaylioglu M, Lipton SA: Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature. 2001, 412 (6847): 641-647. 10.1038\/35088074.","journal-title":"Nature"},{"issue":"4","key":"1081_CR36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.mcn.2005.04.009","volume":"29","author":"A Kretz","year":"2005","unstructured":"Kretz A, Happold CJ, Marticke JK, Isenmann S: Erythropoietin promotes regeneration of adult CNS neurons via Jak2\/Stat3 and PI3K\/AKT pathway activation. Mol Cell Neurosci. 2005, 29 (4): 569-579. 10.1016\/j.mcn.2005.04.009.","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"1081_CR37","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1073\/pnas.0307823100","volume":"101","author":"R Bianchi","year":"2004","unstructured":"Bianchi R, Buyukakilli B, Brines M, Savino C, Cavaletti G, Oggioni N, Lauria G, Borgna M, Lombardi R, Cimen B, et al.: Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci USA. 2004, 101 (3): 823-828. 10.1073\/pnas.0307823100.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1081_CR38","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/0014-4886(87)90132-4","volume":"97","author":"P de Koning","year":"1987","unstructured":"de Koning P, Neijt JP, Jennekens FG, Gispen WH: Org.2766 protects from cisplatin-induced neurotoxicity in rats. Exp Neurol. 1987, 97 (3): 746-750. 10.1016\/0014-4886(87)90132-4.","journal-title":"Exp Neurol"},{"issue":"1","key":"1081_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994, 53 (1): 55-63. 10.1016\/0165-0270(94)90144-9.","journal-title":"J Neurosci Methods"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2202-10-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2202-10-77\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2202-10-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T18:09:06Z","timestamp":1589998146000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/1471-2202-10-77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,15]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1186\/1471-2202-10-77","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,15]]},"article-number":"77"}}